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Dear Editor,
We would like to thank you for your interest in
our review paper entitled “Radiological approaches to
COVID-19 pneumonia” published in the latest issue of
Turkish Journal of Medical Sciences. Principally, in this
review, we aimed to discuss the approach to COVID-19
pneumonia from the perspective of a clinician. We would
like to highlight the points regarding the authors’ concerns
with related literature.
The authors’ first comment is that chest computed
tomography (CT) indications should not be broad in
COVID-19 pneumonia. We penned this review based
on the experiences and observations of clinicians from
various countries related with COVID-19. The definition
of “suspected case” is made based on the symptoms of a
patient. The role of chest CT in diagnosis of a suspected
COVID-19 pneumonia case and its guiding characteristics
in treatment is detailed in the outpatient clinic and
emergency patient management algorithm of the Ministry
of Health of the Republic of Turkey [1]. In this approach, an
unenhanced chest CT is needed if the direct radiography
is normal or nondiagnostic. Many pulmonologists in
Turkey manage COVID-19 cases considering such
algorithms according to the guidelines. Chest CT is an
important diagnostic tool that strengthens the hands of
pulmonologists in the diagnosis of COVID-19 pneumonia
[2].
In their letter, the authors suggested that CT indication
should be limited to the expected benefit that can lead to a
change in the treatment or management of the patient. In
accordance with this suggestion, indeed, we stated that the
result of CT images might change the management and
treatment of suspected COVID-19 cases, in our review.
The authors’ second comment is an objection to our
interpretation that nodular appearances are atypical on
both lower lobes in the first image. These appearances
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are not ground glass opacities. We interpreted these
images as atypical, in that they are “round shaped, small
nodules”, according to an expert consensus statement in
the literature [3]. It is obvious that debate on definition
and standardization of classifications are present in the
literature. In Figure 6, while the multifocal consolidations
in the right lung are more distinct, an interpretation of the
existence of bilateral infiltration is made by the authors.
We insist on our consideration that the infiltration in the
sampled sections is unilateral.
We thank authors for the additional radiological
findings provided in the third comment. These outlined
issues are important radiological details in cases with
COVID-19 pneumonia. We appreciate for their valuable
contributions.
Visual quantitative evaluation for assessing COVID-19
burden as mentioned in the fourth comment was out of
focus in our review. In our review, we did not suggest
that chest CT would be used for screening purposes.
Chest X-ray and chest CT are diagnostic tools for cases
that meet the description of suspicious cases based on
symptoms in triage (1). In a recent publication, Congliang
M et al. emphasized that chest CT imaging has become
the indispensable means not only in the early detection
and diagnosis but also in monitoring the clinical course,
evaluating the disease severity, and may be presented as
an important warning signal preceding the negative RTPCR test results [4]. As this recent paper was published
after our review, we are only able to cite it in this short
letter. If this result is verified with further future studies,
the importance of chest CT in COVID-19 pneumonia
diagnosis should be underlined even further.
However, it is a fact that, we as clinicians, have used
chest CT for the diagnosis of COVID-19 pneumonia in an
essential indication, and it seems that we will continue to
use it in this way. Moreover, we would like to emphasize
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that real time polymerase chain reaction (RT- PCR) test
of the nasopharyngeal and oropharyngeal swab samples
is the standard diagnostic tool [5]. However, ordering CT
scan for patients with suspected COVID-19 pneumonia in
situations such as delaying PCR results or a false negative
result in a patient with strong suspicion of disease is still a
debate in literature [5,6].
Easy access of all suspicious and confirmed COVID-19
pneumonias to healthcare services and their appropriate
management and early initiation of treatment, and a
relatively young population explain the lower mortality

rates in Turkey (2.76%, by 14th May, 2020) when compared
to other countries (7). The opinions of the Fleischner
Society that were mentioned in the authors’ letter are not
addressed among the references in our review. Information
on COVID- 19 is being revised every day based on new
experiences with a multidisciplinary approach. Some of
the argued opinions may be disproved by new ones in
time. This is an expected situation considering the nature
of scientific development. We would like to thank authors’
contributions and perspective which have enriched our
manuscript.
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